Merger Pending
Covetrus and MWI Animal Health merger
US$3.5bn enterprise value
Announced 18 Feb 2026
Advisers
MWI Animal Health
Target
- Financial adviser
- Legal adviser
- Target
- MWI Animal Health
- Acquirer
- Covetrus
- Seller
- Cencora
- Target based in
- United States
- Buyer based in
- United States
- Seller based in
- United States
- Sector
- Animal Health
- Tags
- Animal Health, Distribution, Healthcare
In the league tables
- M&A financial advisers, 2026 to date Goldman Sachs #2 · Morgan Stanley #6 · Wells Fargo Securities #8 · Guggenheim Securities #17 · TD Securities #21 · Deutsche Bank #24 · Greenhill #46 · Rabobank #56 · ING #59 · Natixis #59 · Societe Generale #59 · Standard Chartered #59
- M&A legal advisers, 2026 to date Latham & Watkins #2 · Debevoise & Plimpton #9 · Freshfields #11
Similar deals
- Quadria Capital-led consortium acquisition of Apex Healthcare Berhad Feb 2026 · Pharma
- Apollo stake in newly established entity holding Bayer's long-acting reversible contraceptives (LARC) business Jul 2026 · US$3.5bn · Pharma
- ADI Global Distribution demerger Jul 2025 · US$2.7bn · Distribution
- Thermo Fisher Scientific acquisition of Solventum purification and filtration (P&F) business Sep 2025 · US$4bn · Medtech
- Jardine Matheson acquisition of I-MED Radiology Network May 2026 · US$2.4bn · Healthcare Services
Sources
- Feb 2026 Guggenheim Securities: Lead Financial Advisor to Cencora on its Merger of MWI Animal Health With Covetrus a Portfolio Company of CD&R and TPG guggenheimsecurities.com
- 18 Feb 2026 Press release (EX-99.1, exhibit), CONFIDENTIAL – Press Release sec.gov
- 18 Feb 2026 Debevoise Serves as Lead Transaction Counsel to Covetrus, a CD&R and TPG Portfolio Company, in Its Merger with MWI Animal Health, Valuing MWI at $3.5 Billion debevoise.com
- 18 Feb 2026 Freshfields Advises Cencora in Merger of MWI Animal Health and Covetrus freshfields.com





